ArticlebioRxiv : the preprint server for biology2026
Targeting NAT10 Activates Tumor-Intrinsic Immunity and Suppresses Tumor Progression in Head and Neck Squamous Cell Carcinoma.
Thurbu Tshering Lepcha et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.